+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Intragastric Balloon Market By Administration, By Type, By Filling Material, By End Use, By Country, Industry Analysis and Forecast, 2020 - 2026

  • PDF Icon

    Report

  • 81 Pages
  • April 2020
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5026274
The Latin America, Middle East and Africa Intragastric Balloon Market is expected to witness market growth of 13.4% CAGR during the forecast period (2020-2026).

Increased use of minimally invasive techniques over the forecast period is expected to boost market growth. Intragastric balloons are orally introduced and do not require any incision accompanied by balloon inflation with a saline solution or gas. Growing approval of the intragastric balloon system will serve as useful non-surgical treatment options for the treatment of diseases linked to obesity and weight.

Saline-filled intragastric balloon business accounted for a substantial market share. Ability to reduce weight more efficiently and rapidly by methylene blue dye to detect silicone balloon deflation and will benefit the adoption rate. The American Society of Gastrointestinal Endoscopy indicates that most patients undergoing saline-filled intragastric balloon treatment tend to lose around a quarter of their body mass. As a result, the above-mentioned factors will foster future segmental growth.

The gas-filled balloon market is anticipated to rise at an exponential growth rate over the forecast period. The segmental growth is attributed to three layers of bacteria-resistant material, which reduces the chances of undesirable effects and improves the comfort of patients in the event of deflation. In addition, the balloon's quality to improve patient compliance in spontaneous deflation removal and avoidance will stimulate market growth rate.

Based on Administration, the market is segmented into Endoscopy and Pill Form. Based on Type, the market is segmented into Single, Dual and Triple. Based on Filling Material, the market is segmented into Gas Filled and saline Filled. Based on End Use, the market is segmented into Clinics, Hospitals and Ambulatory Surgical Centers. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sientra, Inc. (Silimed, Inc.), Apollo Endosurgery, Inc., Obalon Therapeutics, Inc., ReShape Lifesciences Inc., Allurion Technologies, Inc., Helioscopie SA (Sante Actions Group), Districlass Medical SA, Spatz FGIA, Inc., Duomed Group (Life Partners Europe), Medsil

Scope of the Study

Market Segmentation:

By Administration
  • Endoscopy and
  • Pill Form

By Type
  • Single
  • Dual and
  • Triple

By Filling Material
  • Gas Filled and
  • Saline Filled

By End Use
  • Clinics
  • Hospitals and
  • Ambulatory Surgical Centers

By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled:
  • Sientra, Inc. (Silimed, Inc.)
  • Apollo Endosurgery, Inc.
  • Obalon Therapeutics, Inc.
  • ReShape Lifesciences Inc.
  • Allurion Technologies, Inc.
  • Helioscopie SA (Sante Actions Group)
  • Districlass Medical SA
  • Spatz FGIA, Inc.
  • Duomed Group (Life Partners Europe)
  • Medsil

Unique Offerings from the Publisher:
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Intragastric Balloon Market, by Administration
1.4.2 LAMEA Intragastric Balloon Market, by Type
1.4.3 LAMEA Intragastric Balloon Market, by Filling Material
1.4.4 LAMEA Intragastric Balloon Market, by End Use
1.4.5 LAMEA Intragastric Balloon Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Intragastric Balloon Market by Administration
3.1 LAMEA Endoscopy Market by Country
3.2 LAMEA Pill Form Market by Country
Chapter 4. LAMEA Intragastric Balloon Market by Type
4.1 LAMEA Single Market by Country
4.2 LAMEA Dual Market by Country
4.3 LAMEA Triple Market by Country
Chapter 5. LAMEA Intragastric Balloon Market by Filling Material
5.1 LAMEA Gas Filled Intragastric Balloon Market by Country
5.2 LAMEA Saline Filled Intragastric Balloon Market by Country
Chapter 6. LAMEA Intragastric Balloon Market by End-use
6.1 LAMEA Clinics Intragastric Balloon Market by Country
6.2 LAMEA Hospitals Market by Country
6.3 LAMEA Ambulatory Surgical Centers Market by Country
Chapter 7. LAMEA Intragastric Balloon Market by Country
7.1 Brazil Intragastric Balloon Market
7.1.1 Brazil Intragastric Balloon Market by Administration
7.1.2 Brazil Intragastric Balloon Market by Type
7.1.3 Brazil Intragastric Balloon Market by Filling Material
7.1.4 Brazil Intragastric Balloon Market by End-use
7.2 Argentina Intragastric Balloon Market
7.2.1 Argentina Intragastric Balloon Market by Administration
7.2.2 Argentina Intragastric Balloon Market by Type
7.2.3 Argentina Intragastric Balloon Market by Filling Material
7.2.4 Argentina Intragastric Balloon Market by End-use
7.3 UAE Intragastric Balloon Market
7.3.1 UAE Intragastric Balloon Market by Administration
7.3.2 UAE Intragastric Balloon Market by Type
7.3.3 UAE Intragastric Balloon Market by Filling Material
7.3.4 UAE Intragastric Balloon Market by End-use
7.4 Saudi Arabia Intragastric Balloon Market
7.4.1 Saudi Arabia Intragastric Balloon Market by Administration
7.4.2 Saudi Arabia Intragastric Balloon Market by Type
7.4.3 Saudi Arabia Intragastric Balloon Market by Filling Material
7.4.4 Saudi Arabia Intragastric Balloon Market by End-use
7.5 South Africa Intragastric Balloon Market
7.5.1 South Africa Intragastric Balloon Market by Administration
7.5.2 South Africa Intragastric Balloon Market by Type
7.5.3 South Africa Intragastric Balloon Market by Filling Material
7.5.4 South Africa Intragastric Balloon Market by End-use
7.6 Nigeria Intragastric Balloon Market
7.6.1 Nigeria Intragastric Balloon Market by Administration
7.6.2 Nigeria Intragastric Balloon Market by Type
7.6.3 Nigeria Intragastric Balloon Market by Filling Material
7.6.4 Nigeria Intragastric Balloon Market by End-use
7.7 Rest of LAMEA Intragastric Balloon Market
7.7.1 Rest of LAMEA Intragastric Balloon Market by Administration
7.7.2 Rest of LAMEA Intragastric Balloon Market by Type
7.7.3 Rest of LAMEA Intragastric Balloon Market by Filling Material
7.7.4 Rest of LAMEA Intragastric Balloon Market by End-use
Chapter 8. Company Profiles
8.1 Sientra, Inc. (Silimed, Inc.)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.2 Apollo Endosurgery, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Approvals:
8.3 Obalon Therapeutics, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals:
8.3.5.2 Partnerships, Collaborations, and Agreements:
8.3.5.3 Geographical Expansions:
8.4 ReShape Lifesciences, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research and Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 Allurion Technologies, Inc.
8.5.1 Company Overview
8.6 Helioscopie SA (Sante Actions Group)
8.6.1 Company Overview
8.7 Districlass Medical SA
8.7.1 Company Overview
8.8 Spatz FGIA, Inc.
8.8.1 Company Overview
8.9 Duomed Group (Life Partners Europe)
8.9.1 Company Overview
8.1 Medsil
8.10.1 Company Overview

Companies Mentioned

  • Sientra, Inc. (Silimed, Inc.)
  • Apollo Endosurgery, Inc.
  • Obalon Therapeutics, Inc.
  • ReShape Lifesciences Inc.
  • Allurion Technologies, Inc.
  • Helioscopie SA (Sante Actions Group)
  • Districlass Medical SA
  • Spatz FGIA, Inc.
  • Duomed Group (Life Partners Europe)
  • Medsil

Methodology

Loading
LOADING...